BRUCELLA GREEN VAC S.L.
We develop a new generation of brucella vaccines, being BGV1 our 1st product, addressed to sheep and goat (€2.7bn SAMs)
The use of BGV1 strain as a medicament for the treatment and/or prevention of brucellosis
Know more of this patent
Under evaluation at least till: 5th of October